Details of the Drug
General Information of Drug (ID: DMRC7V8)
| Drug Name |
1-(4-methoxyphenyl)-2-(phenylsulfonyl)ethanone
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
CHEMBL238620; 27918-37-2; 1-(4-methoxyphenyl)-2-(phenylsulfonyl)ethanone; 1-(4-methoxyphenyl)-2-(phenylsulfonyl)-1-ethanone; AC1N74YZ; Oprea1_356612; 2-(benzenesulfonyl)-1-(4-methoxyphenyl)ethanone; SCHEMBL6203408; CTK0J2325; DTXSID00401432; MolPort-002-876-892; ZINC399878; KS-00003CN3; BDBM50212535; AKOS005097711; 7H-365S; MCULE-5138703884; 4'-Methoxy-alpha-(phenylsulfonyl)acetophenone; 4'-METHOXY-2-(PHENYLSULFONYL)ACETOPHENONE; Ethanone, 1-(4-methoxyphenyl)-2-(phenylsulfonyl)-
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 290.3 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.5 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


